| scholarly article | Q13442814 |
| P2093 | author name string | Marc Tischkowitz | |
| Matina Prapa | |||
| Joyce Solomons | |||
| P2860 | cites work | Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing | Q24632270 |
| Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment | Q33796155 | ||
| Counselling framework for moderate-penetrance cancer-susceptibility mutations | Q33911135 | ||
| Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2. | Q34103057 | ||
| Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes | Q34356721 | ||
| Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients | Q34477375 | ||
| Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer | Q34996647 | ||
| Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer. | Q35736188 | ||
| Gene-panel sequencing and the prediction of breast-cancer risk | Q36175072 | ||
| Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
| Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer | Q36915151 | ||
| No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing | Q37079859 | ||
| Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model | Q37378034 | ||
| Hereditary ovarian and breast cancer: what have we learned? | Q38153188 | ||
| Hereditary breast cancer: the era of new susceptibility genes | Q39657506 | ||
| A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients | Q40700340 | ||
| Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. | Q44217660 | ||
| Association analysis identifies 65 new breast cancer risk loci. | Q45979098 | ||
| Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment. | Q45985357 | ||
| Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles | Q56625730 | ||
| Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel | Q85247141 | ||
| P433 | issue | 6 | |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 568-572 | |
| P577 | publication date | 2017-12-01 | |
| P1433 | published in | Clinical Medicine | Q5133773 |
| P1476 | title | The use of panel testing in familial breast and ovarian cancer | |
| P478 | volume | 17 |
Search more.